These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Removal of heparin and protamine from plasma. Thompson AR; Counts RB J Lab Clin Med; 1976 Dec; 88(6):922-9. PubMed ID: 993645 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the quantitative action of protamine and heparin on blood coagulation. Significance in clinical and laboratory usage. Perkash A Am J Clin Pathol; 1980 May; 73(5):676-81. PubMed ID: 7377134 [TBL] [Abstract][Full Text] [Related]
6. Letter: To use or not to use heparin in neonates with indwelling umbilical catheters. Mahoney DH J Pediatr; 1976 Aug; 89(2):339-40. PubMed ID: 940044 [No Abstract] [Full Text] [Related]
8. Prevention of umbilical artery catheter clots with heparinized infusates. David RJ; Merten DF; Anderson JC; Gross S Dev Pharmacol Ther; 1981; 2(2):117-26. PubMed ID: 7472106 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats. Diness V; Ostergaard PB Thromb Haemost; 1986 Dec; 56(3):318-22. PubMed ID: 3563964 [TBL] [Abstract][Full Text] [Related]
11. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate. Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496 [TBL] [Abstract][Full Text] [Related]
12. A facile colorimetric protamine titration method. Teng CL; Yang VC J Lab Clin Med; 1989 Apr; 113(4):498-504. PubMed ID: 2467958 [TBL] [Abstract][Full Text] [Related]
13. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay. Kitchen S; Theaker J; Preston FE Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006 [TBL] [Abstract][Full Text] [Related]
14. Disorders of coagulation in the newborn. Seshadri RS; Goodall K Paediatrician; 1980; 9(2):90-101. PubMed ID: 7393616 [No Abstract] [Full Text] [Related]
15. Complications of heparin therapy. Gervin AS Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648 [TBL] [Abstract][Full Text] [Related]
16. INADVERTENT SODIUM HEPARIN ADMINISTRATION TO A NEWBORN INFANT. GLUECK HI; LIGHT IJ; FLESSA H; SUTHERLAND JM JAMA; 1965 Mar; 191():1031-2. PubMed ID: 14257736 [No Abstract] [Full Text] [Related]
17. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291 [TBL] [Abstract][Full Text] [Related]
18. The administration of anticoagulants. MARPLE CD Calif Med; 1950 Aug; 73(2):166-70. PubMed ID: 15426992 [TBL] [Abstract][Full Text] [Related]
19. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest. Godal HC; Gjengedal G Scand J Haematol; 1971; 8(3):194-9. PubMed ID: 5093996 [No Abstract] [Full Text] [Related]
20. [Control of the heparin induced bleeding risk in haemodialysis patients (author's transl)]. Vogel GE; Kopp KF Med Klin; 1976 Jan; 71(3):116-9. PubMed ID: 1250190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]